
74: 2 Fast 2 Feverish: Late ID Complications of CAR-T therapy
Febrile
00:00
Cloit Infections After CD19 CAR-T
IgG levels reached their nadir at 6 months, and then about half of the patients did not need immunoglobulin replacement therapy. Another study of 41 patients with large B-cell lymphoma who also got the access out, 10% had hypogamagma prior to lymphodifluition. It seems that lower rates have been reported with other CD19 products.
Transcript
Play full episode